Announcements Trials
Browse Landscape

Phase

Phase 2 4

Status

Terminated 2Completed 2

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Head & Neck 4Other 3

Conditions

Esophageal Neoplasms 25Rectal Neoplasms 23Glioblastoma 23Prostatic Neoplasms 19Carcinoma, Non-Small-Cell Lung 17Breast Neoplasms 17Pancreatic Neoplasms 16Lung Neoplasms 16Squamous Cell Carcinoma of Head and Neck 14Head and Neck Neoplasms 14Neoplasms 12Oropharyngeal Neoplasms 11Neoplasm Metastasis 10Esophageal Squamous Cell Carcinoma 9Adenocarcinoma Of Esophagus 8Uterine Cervical Neoplasms 7Glioma 7Triple Negative Breast Neoplasms 6Stomach Neoplasms 6Gliosarcoma 6Carcinoma, Squamous Cell 6Brain Neoplasms 6Urinary Bladder Neoplasms 5Nasopharyngeal Carcinoma 5Melanoma 5Laryngeal Neoplasms 5Colorectal Neoplasms 5Xerostomia 4Sarcoma 4Mouth Neoplasms 4

Interventions

Radiation 4Radiotherapy 3Surgical Procedures, Operative 2Cisplatin 2Amifostine 2pegfilgrastim 1Selenomethionine 1Saliva, Artificial 1Paclitaxel 1Hypnosis 1Granulocyte Colony-Stimulating Factor 1Fluorouracil 1Filgrastim 1Docetaxel 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Xerostomia × Radiation × Clear all
NCT00352118 2017-12-28

Combination Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer

Masonic Cancer Center, University of Minnesota

Phase 2 Terminated
4 enrolled 4 charts
Head & NeckOther

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Xerostomia, Mucositis

NCT00095927 2017-01-04

Randomized Amifostine For SCCHN

Dana-Farber Cancer Institute

Phase 2 Completed
58 enrolled
Head & NeckOther

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Radiation Injuries, Xerostomia, Mucositis

NCT00168116 2016-02-24

Xerostomia in Head and Neck Cancer Patients Receiving Radiation as the Primary Treatment Versus Patients Who Will Not Have Such a Procedure

AHS Cancer Control Alberta

Phase 2 Completed
42 enrolled
Head & Neck

Head and Neck Neoplasms, Xerostomia

NCT01682031 2014-08-22

Selenomethionine in Reducing Mucositis in Patients With Locally Advanced Head and Neck Cancer Who Are Receiving Cisplatin and Radiation Therapy

Roswell Park Cancer Institute

Phase 2 Terminated
18 enrolled 8 charts
Head & NeckOther

Squamous Cell Carcinoma of Head and Neck, Radiation Injuries, Xerostomia, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡